Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci.
about
Determining Linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national release.Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumptionThe oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioningR chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistanceGenome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistanceIn vitro activities of the Rx-01 oxazolidinones against hospital and community pathogensActivity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: report from the SENTRY Antimicrobial Surveillance ProgramResistance to linezolid caused by modifications at its binding site on the ribosomePerformance of TaqMan array card to detect TB drug resistance on direct specimens.Polyphyletic emergence of linezolid-resistant staphylococci in the United StatesNovel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcusWhole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations.Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics.In vitro activity of linezolid against key gram-positive organisms isolated in the united states: results of the LEADER 2004 surveillance program.Identification of vat(E) in Enterococcus faecalis isolates from retail poultry and its transferability to Enterococcus faeciumMutations in 23S rRNA at the peptidyl transferase center and their relationship to linezolid binding and cross-resistance.Comparison of testing methods for detection of decreased linezolid susceptibility due to G2576T mutation of the 23S rRNA gene in Enterococcus faecium and Enterococcus faecalis.Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage.Linezolid for the treatment of drug-resistant infections.Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes.Inactivation of the indigenous methyltransferase RlmN in Staphylococcus aureus increases linezolid resistanceNovel agents for the treatment of resistant Gram-positive infections.Antimicrobials: modes of action and mechanisms of resistance.Resistance to linezolid. Are we surprised? How hard should we look?Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.Multiple roles for Enterococcus faecalis glycosyltransferases in biofilm-associated antibiotic resistance, cell envelope integrity, and conjugative transfer.Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.Enterococcus faecalis resistant to linezolid: case series and review of the literature.Antimicrobial resistance to linezolid.Mutations in the DNA mismatch repair proteins MutS and MutL of oxazolidinone-resistant or -susceptible Enterococcus faecium.Clinical update on linezolid in the treatment of Gram-positive bacterial infections.Detection of a cfr(B) Variant in German Enterococcus faecium Clinical Isolates and the Impact on Linezolid Resistance in Enterococcus spp.The ribosomal peptidyl transferase center: structure, function, evolution, inhibition.Intrinsic and acquired resistance mechanisms in enterococcus.Genomic Sequence of a Clinical Vancomycin-Resistant Reference Strain, Enterococcus faecalis ATCC 51299.Emergence of clonal complex 17 Enterococcus faecium in The Netherlands.Antibiotics and the ribosome.Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase.An infection with linezolid-resistant S. aureus in a patient with left ventricular assist system.Linezolid: effectiveness and safety for approved and off-label indications.
P2860
Q24535971-ECF51F92-8604-4FAA-A326-F2D1276F999DQ24643142-CB28BB85-2D01-4A4B-A136-B3293B6F4901Q24652742-6B6409B2-F900-435A-81E7-94A38773618DQ24653939-D3546F1A-C491-44C5-89BA-F826760E9D38Q24655140-171102D9-601A-477C-BADB-A9EAD38CA564Q24656140-65364A71-DD5D-450E-9585-CEE121361F4AQ24681027-ED174BDD-6E9B-4EB9-9E75-EBDEE3871213Q27006772-831E05BB-B893-46E9-87AB-3033241E6F23Q30252470-AD411A93-4D69-4412-90EB-8913A8CF638DQ33613747-21C13245-656E-415C-B422-DADAD681E5B4Q33938088-9952D81D-EA0F-4D3C-AA67-1AD820EB84C2Q34049640-2299240E-AC92-4F6C-8CA3-87F08CE85AE6Q34189984-0FBE4C03-55CD-4017-B1C7-381CC27E4614Q34228269-B2F9CC25-CC04-4B05-8F16-5A64215D2C13Q34252056-835B773F-D55A-4719-9E08-1604BD24EDE1Q34289995-37474E6D-C227-407B-96C5-2D1FD9ED454BQ34431930-075E1EB5-BA79-492B-9DC4-826BEEF8C8FAQ34431963-E331D1B4-BCCC-4AD7-8947-C7B969675909Q34894133-4B3E00A8-E1B3-43D0-AE23-8D006E90EE15Q34999291-B981EE88-DD82-45A2-B060-7D24FDA04F5DQ35005203-C8EB90A9-FC20-4168-85E3-1B845E629C0AQ35056042-2438AC3A-2CC7-4A2F-AAC1-43315777E232Q35127138-F1C3E989-4DAD-4222-8759-E0BD758F0853Q35139266-406141E5-1124-4749-802B-8046E76295A2Q35215431-78325167-C420-4D21-9BFE-E97EB76C94FEQ35616215-49DEF623-5742-4DA8-AA75-AD498010AD4BQ35635797-C562BFA1-508D-4C34-B959-89E64A971651Q35906331-603BC13A-0AAB-4C14-BF24-C54C2B87EEDEQ35912430-EB6677D1-B241-4E7A-8291-EF6BCA7C8BD3Q36048384-CFA98D01-D439-4CB6-9547-22448F3086B4Q36083208-585621AC-4908-49AB-84CE-EA6C24BCB6C3Q36205566-D76B0ECC-3FC1-4A2D-B0E3-B39428FC4165Q36300790-51A29F9D-EAFE-4750-A1EC-FB70DC7BFAE0Q36362547-0BD3E1F1-43CF-4FEC-943E-05DF7F7139AFQ36381868-F142E21D-C23B-4BFC-8710-86801A1457EBQ36423673-449F4D44-6982-434C-8708-9E083CB1AFDFQ36428625-137DDDB7-0DB9-4E91-BA2E-C8956EA49EBEQ36497918-8403B56B-C847-48EA-9D07-E402262B7750Q36804106-4B8FCFAA-262F-41FE-98D6-61FB10346E9CQ36967288-E89D275C-875D-464B-A0E8-1C253E7E8D67
P2860
Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Resistance to linezolid: chara ...... comycin-resistant enterococci.
@ast
Resistance to linezolid: chara ...... comycin-resistant enterococci.
@en
type
label
Resistance to linezolid: chara ...... comycin-resistant enterococci.
@ast
Resistance to linezolid: chara ...... comycin-resistant enterococci.
@en
prefLabel
Resistance to linezolid: chara ...... comycin-resistant enterococci.
@ast
Resistance to linezolid: chara ...... comycin-resistant enterococci.
@en
P2093
P2860
P1476
Resistance to linezolid: chara ...... comycin-resistant enterococci.
@en
P2093
D L Shinabarger
F Siddiqui
G A Noskin
J Prystowsky
L R Peterson
P2860
P304
P356
10.1128/AAC.45.7.2154-2156.2001
P407
P577
2001-07-01T00:00:00Z